In situ gels: The mechanism of formation and its application in controlled-release drug delivery

Chinese Pharmaceutical Journal

Volumn 38, Issue 8, 2003, Pages 564-568

  Wei, Gang ^a   Xu, Hui ^a   Zheng, Jun Min ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBOMER; CELLACEFATE; ETHYL CELLULOSE; ETHYLHYDROXYETHYLCELLULOSE; GELRITE; ONCOGEL; POLOXAMER; POLYCAPROLACTONE; POLYMER; REGEL; TIMOLOL MALEATE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; GEL; INFRARED SPECTROSCOPY; PSEUDOMONAS;

EID: 0141761141     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Edsman K, Carlfors J, Petersson R. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use [J]. Eur J Pharm Sci, 1998, 6(1):105.
2. Cabana A, Ait-Kadi A, Juhasz J. Study of the gelation process of polyethylene oxide-polypropylene oxide-polyethylene oxide copolymer (poloxamer 407) aqueous solutions [J]. J Colloid Interface Sci, 1997, 190(2):307.
3. Bohorquez M, Koch C, Trygstad T, et al. A study of the temperature-dependent micellization of Pluronic F127 [J]. J Colloid Interface Sci, 1999, 216(1):34.
4. Suh H, Jun HW. Physicochemical and release studies of naproxen in poloxamer gels [J]. Int J Pharm, 1996, 129(1):13.
5. Pandit N, Wang D. Salt effects on the diffusion and release rate of propranolol from poloxamer 407 gels [J]. Int J Pharm, 1998, 167(1-2):183.
6. Moore T, Croy S, Mallapragada SK, et al. Experimental investigation and mathematical modeling of Pluronic(r) F127 gel dissolution: drug release in stirred systems [J]. J Controlled Release, 2000, 67(2-3):191.
7. Anderson BC, Pandit NK, Mallapragada SK. Understanding drug release from poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) gels [J]. J Controlled Release, 2001, 70 (1-2):157.
8. Desai SD, Blanchard J. In vitro evaluation of Pluronic F127-based controlled-release ocular delivery systems for pilocarpine [J]. J Pharm Sci, 1998, 87(2):226.
9. Choi HG, Oh YK, Kim CK. In situ gelling and mucoadhesive liquid suppository containing acetaminophen: enhanced bioavailability [J]. Int J Pharm, 1998, 165(1):23.
10. Bochot A, Fattal E, Gulik A, et al. Liposomes dispersed within a thermosensitive gel: A new dosage form for ocular delivery of oligonucleotides [J]. Phrm Res, 1998, 15(9):1364.
11. Yun MO, Choi HG, Jung JH, et al. Development of a thermo-reversible insulin liquid suppository with bioavailability enhancement [J]. Int J Pharm, 1999, 189(2):137.
12. Desai SD, Blanchard J. Evaluation of Pluronic F127 sustained-release ocular delivery systems for pilocarpine using the albino rabbit eye model [J]. J Pharm Sci, 1998, 87(10):1190.
13. Shin SC, Cho CW, Oh IJ. Effect of non-ionic surfactants as permeation enhancers towards piroxicam from the poloxamer gel through rat skins [J]. Int J Pharm, 2001, 222(2):199.
14. Wei G, Xu H, Ding PT, et al. Thermosetting gels with modulated gelation temperature for ophthalmic use: rheological and gamma scintigraphic studies [J]. J Controlled Release, 2002, 83(1):65.
15. Bromberg L, Orkisz M, Roos E, et al. Interpenetrating networks of poloxamer copolymers and poly(acrylic acid) as vehicles in controlled drug delivery [J]. J Controlled Release, 1997, 48(2): 305.
16. Jeong B, Bae YH, Lee DS, et al. Biodegradable block copolymer as injectable drug-delivery system [J]. Nature, 1997, 388(28): 860.
17. Jeong B, Bae YH, Kim SW. Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers [J]. J Controlled Release, 2000, 63(1):155.
18. Zentner GM, Rathi R, Shih C, et al. Biodegradable block copolymer for delivery of proteins and water-insoluble drug [J]. J Controlled Release, 2001, 72(1):203.
19. Lee JW, Hua FJ, Lee DS. Thermoreversilble gelation of biodegradable poly-(ε-caprolactone) and poly(ethylene glycol) multiblock copolymers in aqueous solutions[J]. J Controlled Release, 2001, 73(2):315.
20. Ridell A, Evertsson H, Nilsson S, et al. Amphiphilic association of ibuprofen and two nonionic cellulose derivatives in aqueous solution [J]. J Pharm Sci, 1999, 88(11):1175.
21. Miyazaki A, Suisha F, Kawasaki N, et al. Thermally reversible xyloglucan gels as vehicles for rectal drug delivery [J]. J Controlled Release, 1998, 56(1):75.
22. Suisha F, Kawasaki N, Miyazaki A, et al. Xyloglucan gels as sustained release vehicles for the intraperitoneal administration of mitomycin C [J]. Int J Pharm, 1998, 172(1):27.
23. Kawasaki N, Ohkura R, Miyazaki S, et al. Thermally reversible xyloglucan gels as vehicles for oral drug delivery [J]. Int J Pharm, 1999, 181(2):227.
24. Miyazaki S, Suzuki S, Kawasaki N, et al. In situ gelling xyloglucan formulation for sustained release ocular delivery of pilocarpine hydrochloride [J]. Int J Pharm, 2001, 229(1):29.
25. Paulsson M, Hägerstöm H, Edsman K. Rheological studies of the gelation of deacetylated gellan gum (Gelrite(r)) in physiological conditions [J]. Eur J Pharm Sci, 1999, 9(1):99.
26. Carfors J, Edsman K, Petersson R, et al. Rheological evaluation of Gelrite® in situ gels for ophthalmic use [J]. Eur J Pharm Sci, 1998, 6(2):113.
27. Miyazaki S, Aoyama H, Kawasaki N, et al. In situ gelling gellan formulations as vehicles for oral delivery [J]. J Controlled Release, 1999, 60(3):287.
28. Katayama H, Nishimura T, Ochi S, et al. Sustained release liquid preparation using sodium alginate for eradication of Helicobacter pylori [J]. Biol Pharm Bull, 1999, 22(1):55.
29. Miyazaki S, Kubo W, Attwood D. Oral sustained delivery of theophylline using in situ gelation of sodium alginate [J]. J Controlled Release, 2000, 67(3):275.
30. Cohen S, Lobel E, Trevgoda A, et al. A novel in situ-forming ophthalmic drug delivery systems from alginates undergoing gelation in the eye [J]. J Controlled Release, 1997, 44(2-3):201.
31. Gurny R, Boye T, Ibrahim H. Ocular therapy with nanoparticulate systems for controlled drug delivery [J]. J Controlled Release, 1985, 2(3):353.
32. Srividya B, Cardoza RM, Amin PD. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system [J]. J Controlled Release, 2001, 73(2):205.
33. Lin HR, Sung KC. Carbopol/pluronic phase change solutions for ophthalmic drug delivery [J]. J Controlled Release, 2000, 69(3): 379.